ArticleGastroenterology and hepatology from bed to bench2025
Association between colorectal cancer stem cells' expression of LGR5 and the location of colorectal cancer.
Article in Gastroenterology and hepatology from bed to bench, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The aim of this study is to assess the association between LGR5 expression, a cancer stem cell marker, and the location of colorectal cancer (CRC). Background: The incidence of chemotherapy-resistant CRC is increasing. The location of CRC is important in determining CRC progression. The area itself is associated with the presence of cancer stem cells. Methods: This cross-sectional study was conducted in Adam Malik Hospital and its sister hospitals. Inclusion criteria were patients who underwent colonoscopy, biopsy, or operation due to CRC, Indonesian, and willing to provide familial medical history regarding CRC and other malignancies up to third-degree relatives. CRC tissue was obtained from each subject as a specimen and underwent immunohistochemistry examination to determine LGR5 expression. Data analysis was performed by SPSS, version 26 (Chicago, 2022). Results: A total of 118 subjects were involved and divided into proximal (32 subjects), distal (43 subjects), and rectal (43 subjects) CRC. Mean age of subjects was 57.30 (SD 12.99) years with 69 (58.5%) subjects were males. The percentage of high-level LGR5 expression was found in subjects with proximal CRC (72%), followed by distal (44.1%) and rectal (39.5%) CRC. There was a significant association between LGR5 expression and the location of CRC (p=0.014). No relationship was observed between LGR5 expression with gender, age, body mass index, hemoglobin level, leukocyte count, platelet count, and histopathology grade of CRC. Conclusion: LGR5 expression is associated with CRC. Higher LGR5 expression is observed in proximal CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.